| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 03/25/2008 | US7347998 Method of delivering therapeutic agents to site of tissue injury |
| 03/20/2008 | WO2008032796A1 Novel vaccine for dog |
| 03/20/2008 | WO2008032219A2 Making influenza virus vaccines without using eggs |
| 03/20/2008 | WO2008031331A1 A recombinant adenovirus target-oriented coexpressing human p53 and p53aip1 |
| 03/20/2008 | WO2007132480A3 A composition useful as a vaccine |
| 03/20/2008 | WO2007047938A3 Influenza viruses able to infect canids, uses thereof |
| 03/20/2008 | US20080070920 Novel HIV reverse transcriptase inhibitors |
| 03/20/2008 | US20080070305 Inhibition of expression of a target gene |
| 03/20/2008 | US20080069839 Isolation and characterization of the precursor virus of human sars virus: sars-associated corona virus-like virus |
| 03/20/2008 | US20080069838 Novel human virus causing severe acute respiratory syndrome (sars) and uses thereof |
| 03/20/2008 | US20080069837 Composition and method for treating cancer using herpes virus |
| 03/20/2008 | US20080069821 Avian pandemic; immunogens; antibodies; immunology |
| 03/20/2008 | US20080069804 Polynucleotides; RNA; helper cells |
| 03/20/2008 | US20080069803 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions vectors |
| 03/20/2008 | CA2663295A1 Alphavirus replicon particles matched to protein antigens as immunological adjuvants |
| 03/19/2008 | EP1900376A2 Synergistic inhibition of HIV-1 fusion and attachment, compsitions and antobodies thereto |
| 03/19/2008 | EP1899470A2 System for rapid production of high-titer and replication-competent adenovirus-free recombinant adenovirus vectors |
| 03/19/2008 | CN100375786C Recombinant MVA capable of expressing structural HCV antigens |
| 03/18/2008 | US7345026 A part of the coding sequence of the middle glycoprotein of the hepatitis B virus, which has a dna sequence coding for at least one tumor epitope of a tumor antigen inserted |
| 03/18/2008 | US7344883 Human embryonic kidney cells and amniocytes; capable of complementing recombinanat adenovirus |
| 03/18/2008 | US7344873 Using vector transformation to generate heat resistant viral particles |
| 03/18/2008 | US7344872 involves engineering a recombinant shuttle vector comprising a nucleic acid cassette encoding prokaryotic green fluorescent protein (GFP) operably linked to regulatory sequences which permit its expression in a host cell |
| 03/18/2008 | US7344723 Self-replicating RNA molecule from hepatitis C virus |
| 03/18/2008 | US7344711 Administering an adenovirus defective in its VAI and VAII virus-associated RNAs |
| 03/18/2008 | CA2448908C Adenovirus protein ix, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization |
| 03/13/2008 | WO2008028535A1 Split-core-particles for the presentation of foreign molecules, especially for vaccine applications, and method for their production |
| 03/13/2008 | WO2007099401A3 Oncolytic attenuated reoviruses for treatment of proliferative disorders |
| 03/13/2008 | US20080064647 A polyvalent multimeric complex formed from a plurality of circularly permuted chimeric pRNA molecules, each carrying a stabilized biologically active moiety; degradation resistant stabilized ribozyme is correctly folded such that it remains intracellularly active |
| 03/13/2008 | US20080064081 Reducing antigenicity of viral protein via amino acid sequence variation; enhancing vector transferability during gene therapy |
| 03/13/2008 | US20080064080 Using nutrient broth comprising polyamines and plant and/or yeast-derived hydrolysate for propagation of transgenic/infected cells |
| 03/13/2008 | US20080064050 Applications of the binding interaction of proanthocyanidins with bacteria and bacterial components |
| 03/13/2008 | US20080063664 making a vaccine by constructing a plasmid comprising a nucleotide sequence encoding proteins of the virus, transfecting cells and gene expression viral proteins; detecting and prevent an infection of SARS-CoV by administering the vaccine; severe acute respiratory syndrome coronavirus |
| 03/13/2008 | US20080063663 immunizing a cat with vaccine against a hemorrhagic feline calicivirus (hFCV); veterinary medicine |
| 03/13/2008 | US20080063662 Vaccine |
| 03/13/2008 | US20080063656 Adenoviral Vector Compositions |
| 03/13/2008 | CA2662707A1 Split-core-particles for the presentation of foreign molecules, especially for vaccine applications, and method for their production |
| 03/13/2008 | CA2653696A1 Recombinant vaccine against bluetongue virus |
| 03/12/2008 | EP1897887A1 Split-core-particles for the presentation of foreign molecules, especially for vaccination purposes and methods for their preparation |
| 03/12/2008 | EP1896069A2 Inactivated chimeric vaccines and related methods of use |
| 03/12/2008 | EP1537872A4 Immunostimulator having antineoplastic action and method for producing said immunostimulator |
| 03/12/2008 | EP1444346B1 Sirna knockout assay method and constructs |
| 03/12/2008 | EP0973538B1 Modified proteins which bind extracellular matrix components |
| 03/12/2008 | CN100374574C Stable adenoviral vectors and methods for propagation thereof |
| 03/12/2008 | CN100374563C Attenuated pestiviruses |
| 03/12/2008 | CN100374560C Configuration of high effect expression serum albumin yeast strain and fermentation purification technology |
| 03/12/2008 | CN100374552C Method of large scale production of hepatitis a virus |
| 03/12/2008 | CN100374551C Compositions comprising viruses and methods for concentrating virus preparations |
| 03/11/2008 | US7341731 HIV-2 antigen compositions |
| 03/11/2008 | US7341729 Recombinant parainfluenza virus expression systems and vaccines |
| 03/06/2008 | WO2007123961A3 Purification processes for isolating purified vesicular stomatitis virus from cell culture |
| 03/06/2008 | US20080057537 Nucleic acid encoding polypeptide involved in cellular entrance of the PRRS virus |
| 03/06/2008 | US20080057082 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; diarrhea therapy |
| 03/06/2008 | US20080057081 Influenza Hemagglutinin And Neuraminidase Variants |
| 03/06/2008 | US20080057078 Chicken Anemia Virus Vaccine from Cell Line |
| 03/06/2008 | US20080057038 bacteriophage-drug conjugates, where the bacteriophage displays on its coat a ligand that endows it with specificity towards target cells, used as high-capacity drug delivery systems |
| 03/06/2008 | US20080057037 Treatment of neoplasms with viruses |
| 03/06/2008 | US20080057036 comprising a Picornavirus capable of lytically infecting or killing a cell substantially in the absence of intercellular adhesion molecule |
| 03/05/2008 | EP1895010A2 Equine infectious anaemia virus (eiav) based vectors |
| 03/05/2008 | EP1895003A1 Cells expressing recombinase |
| 03/05/2008 | EP1894998A1 Method for large scale production of virus antigen |
| 03/05/2008 | EP1893754A2 Novel glutamic acid decarboxylase (gad) chimera and methods of use |
| 03/05/2008 | EP1893752A2 Attenuated sars and use as a vaccine |
| 03/05/2008 | EP1893751A1 Process for the preparative purification of virus-like particles (vlps) |
| 03/05/2008 | EP1893223A1 Highly attenuated pox virus strains, method for the production thereof and the use thereof as paramunity inducers or for producing vector vaccines |
| 03/05/2008 | EP0690912B1 Recombinant avian adenovirus vector |
| 03/05/2008 | CN101137748A Use of a combination of myxoma virus and rapamycin for therapeutic treatment |
| 03/05/2008 | CN101137393A Improved vaccine against feline calicivirus |
| 03/04/2008 | US7338799 Polynucleotide encoding a mouse choline transporter |
| 03/04/2008 | US7338759 HCV variants |
| 03/04/2008 | US7338662 Recombinant poxvirus expressing homologous genes inserted into the foxviral genome |
| 03/04/2008 | US7338661 Infectious bursal disease virus antigenic isolates and vaccines |
| 02/28/2008 | WO2008023572A1 Chimeric adenovirus, method for producing the same and pharmaceutical using the same |
| 02/28/2008 | WO2001070932A3 Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife |
| 02/28/2008 | US20080050795 Mixture Of At Least Two Different Antibodies Specific For Predetermined Antigens And Use Of The Mixture |
| 02/28/2008 | US20080050770 Method for the production and purification of adenoviral vectors |
| 02/28/2008 | US20080050403 Production of viruses, viral isolates and vaccines |
| 02/28/2008 | US20080050402 comprising replacements in the influenza nonstructural 1 (NS1) polypeptide, that interferes with viral replication and phosphatidylinositol 3-kinase activation, used for treating and preventing influenza virus infection |
| 02/28/2008 | US20080050401 Rescue of Influenza Virus |
| 02/28/2008 | US20080050377 consensus sequences and specific sequences for antibodies that specifically bind to STOP-1; angiogenesis and vasculogenesis; antitumor agents |
| 02/28/2008 | US20080050359 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 02/28/2008 | US20080050345 Adeno-associated virus serotype I nucleic acid sequences, vectors and host cells containing same |
| 02/28/2008 | US20080050343 Adeno-associated virus serotype I nucleic acid sequences, vectors and host cell containing same |
| 02/28/2008 | CA2661468A1 Tissue culture system for production of hepatitis c virus |
| 02/27/2008 | EP1892296A1 Generation and selection of recombinant varied binding proteins |
| 02/27/2008 | EP1891438A2 Methods for identifying ligands for stem cells and cells derived therefrom |
| 02/27/2008 | EP1891210A1 Dengue serotype 2 attenuated strain |
| 02/27/2008 | EP1137758B1 Method and composition for preserving adenoviruses |
| 02/27/2008 | CN101130073A Protein expression in baculovirus vector expression systems |
| 02/27/2008 | CN100371342C Foot and mouth disease virus infectious complementary deoxyribonucleic acid and its preparation method |
| 02/26/2008 | US7335501 Derived from fungi of the Penicillium genus; vectors and transformed host organisms containing these polynucleotides encoding the phytases |
| 02/26/2008 | US7335473 Causative agent of the Mystery Swine Disease, vaccine compositions and diagnostic kits |
| 02/26/2008 | US7335366 Attenuated bovine respiratory syncytial virus |
| 02/26/2008 | US7335364 Modified Vaccinia Ankara virus variant |
| 02/26/2008 | US7335353 Porcine cells comprising an adenovirus E3 gene region |
| 02/21/2008 | WO2008022196A2 Development of dengue virus vaccine components |
| 02/21/2008 | WO2008021959A2 Influenza hemagglutinin and neuraminidase variants |
| 02/21/2008 | WO2008021140A2 Recombinant aav production in mammalian cells |
| 02/21/2008 | WO2007124148A3 Treatment of connective tissue disorders |
| 02/21/2008 | WO2006130504A3 Methods for identifying ligands for stem cells and cells derived therefrom |
| 02/21/2008 | US20080044885 Method of separating microorganism using nonplanar solid substrate and device for separating microorganism using the same |